ARCHIVES

FDA Designates Zometa For Priority Review.

This article is from The Cancer Letter archive.

Vol. 27 No. 44 | November 30, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: Simone, LoBuglio Lead AACI; AMA Honors B.J. Kennedy; FDA Meet Patient Advocates

July 31, 1992

Radiotherapy Plus Cetuximab May Control Head/Neck Cancer

November 26, 2010

Lapatinib Improves Outcome Of Advanced Breast Cancer

July 28, 2006

Gori to Hopkins Part Time, Keeps DCCP Deputy Job

September 1, 1978

Reinventing NCI: Prevention Program Lacks Leadership, Reorganization Needed, Advisory Group Says

June 20, 1997

Funding Opportunities: DOD releases PA On Ovarian Cancer

August 6, 1999